Neprilysin Inhibition: A New Therapeutic Option for Type 2 Diabetes?

Diabetologia - Germany
doi 10.1007/s00125-019-4889-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy